Market Research Logo

Global Real World Evidence Solutions Market Analysis & Trends - Industry Forecast to 2027

Global Real World Evidence Solutions Market Analysis & Trends - Industry Forecast to 2027

The Global Real World Evidence Solutions Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include increasing demand on end-to-end real world evidence services, association of artificial intelligence in real-world data management, growing role of wearable devices for real world data.

By therapeutic area, market is categorized into cardiovascular disease, Immunology, oncology, neurology and other therapeutic areas.

Based on component, market is divided into services and data sets. Data sets are sub divided into claims data, patient-powered data, clinical settings data and pharmacy data.

Depending on end user, market is classified into healthcare payers, pharmaceutical & medical device companies, healthcare providers and other end users.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:
North America
- US
- Canada
- Mexico

Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia Pacific

Middle East
- Saudi Arabia
- UAE
- Rest of Middle East

Latin America
- Argentina
- Brazil
- Rest of Latin America

Rest of the World
- South Africa
- Others

Report Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2027, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2027
- Market opportunities and recommendations for new investments


1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 End UserAnalysis
1.5 Strategic Benchmarking
1.6 Opportunity Analysis
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Increasing demand on End-To-End real world evidence services
3.1.2 Association of artificial intelligence in real-world data management
3.1.3 Growing role of wearable devices for real world data
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry
4 Real World Evidence Solutions Market, By Therapeutic Area
4.1 Cardiovascular Disease
4.1.1 Cardiovascular Disease Market Forecast to 2027 (US$ MN)
4.2 Immunology
4.2.1 Immunology Market Forecast to 2027 (US$ MN)
4.3 Oncology
4.3.1 Oncology Market Forecast to 2027 (US$ MN)
4.4 Neurology
4.4.1 Neurology Market Forecast to 2027 (US$ MN)
4.5 Other Therapeutic Areas
4.5.1 Other Therapeutic Areas Market Forecast to 2027 (US$ MN)
5 Real World Evidence Solutions Market, By Component
5.1 Services
5.1.1 Services Market Forecast to 2027 (US$ MN)
5.2 Data Sets
5.2.1 Data Sets Market Forecast to 2027 (US$ MN)
5.2.1.1 Claims Data
5.2.1.1.1 Claims Data Market Forecast to 2027 (US$ MN)
5.2.1.2 Patient-Powered Data
5.2.1.2.1 Patient-Powered Data Market Forecast to 2027 (US$ MN)
5.2.1.3 Clinical Settings Data
5.2.1.3.1 Clinical Settings Data Market Forecast to 2027 (US$ MN)
5.2.1.4 Pharmacy Data
5.2.1.4.1 Pharmacy Data Market Forecast to 2027 (US$ MN)
6 Real World Evidence Solutions Market, By End User
6.1 Healthcare Payers
6.1.1 Healthcare Payers Market Forecast to 2027 (US$ MN)
6.2 Pharmaceutical & Medical Device Companies
6.2.1 Pharmaceutical & Medical Device Companies Market Forecast to 2027 (US$ MN)
6.3 Healthcare Providers
6.3.1 Healthcare Providers Market Forecast to 2027 (US$ MN)
6.4 Other End Users
6.4.1 Other End Users Market Forecast to 2027 (US$ MN)
7 Real World Evidence Solutions Market, By Geography
7.1 North America
7.1.1 North America Market Forecast by Countries to 2027 (US$ MN)
7.1.1.1 US
7.1.1.2 Canada
7.1.1.3 Mexico
7.2 Europe
7.2.1 Europe Market Forecast by Countries to 2027 (US$ MN)
7.2.1.1 Germany
7.2.1.2 U.K
7.2.1.3 Italy
7.2.1.4 France
7.2.1.5 Spain
7.2.1.7 Rest of Europe
7.3 Asia Pacific
7.3.1 Asia Pacific Market Forecast by Countries to 2027 (US$ MN)
7.3.1.1 China
7.3.1.2 Japan
7.3.1.3 India
7.3.1.4 Australia
7.3.1.5 New Zealand
7.3.1.7 Rest of Asia Pacific
7.4 Middle East
7.4.1 Middle East Market Forecast by Countries to 2027 (US$ MN)
7.4.1.1 Saudi Arabia
7.4.1.2 UAE
7.4.1.3 Rest of Middle East
7.5 Latin America
7.5.1 Latin America Market Forecast by Countries to 2027 (US$ MN)
7.5.1.1 Argentina
7.5.1.2 Brazil
7.5.1.3 Rest of Latin America
7.6 Rest of the World (RoW)
7.6.1 RoW Market Forecast by Countries to 2027 (US$ MN)
7.6.1.1 South Africa
7.6.1.2 Others
8 Key Player Activities
8.1 Acquisitions & Mergers
8.2 Agreements, Partnerships, Collaborations and Joint Ventures
8.3 Product Launch & Expansions
8.4 Other Activities
9 Leading Companies
9.1 Clinigen
9.2 Syneos Health
9.3 Oracle
9.4 Perkinelmer
9.5 Parexel
9.6 IBM
9.7 SAS Institute
9.8 Anthem
9.9 Cognizant
9.10 Icon PLC
9.11 Optum (A Subsidiary of United Health Group, Inc.)
9.12 Pharmaceutical Product Development
9.13 Merck
9.14 Iqvia
9.15 Novartis
List of Tables
Table 1 Global Real World Evidence Solutions Market By Region, Market Forecast (2015-2027) (US $MN)
Table 2 Global Real World Evidence Solutions Market By Therapeutic Area, Market Forecast (2015-2027) (US $MN)
Table 3 Global Real World Evidence Solutions Market By Cardiovascular Disease, Market Forecast (2015-2027) (US $MN)
Table 4 Global Real World Evidence Solutions Market By Immunology, Market Forecast (2015-2027) (US $MN)
Table 5 Global Real World Evidence Solutions Market By Oncology , Market Forecast (2015-2027) (US $MN)
Table 6 Global Real World Evidence Solutions Market By Neurology, Market Forecast (2015-2027) (US $MN)
Table 7 Global Real World Evidence Solutions Market By Other Therapeutic Areas, Market Forecast (2015-2027) (US $MN)
Table 8 Global Real World Evidence Solutions Market By Component, Market Forecast (2015-2027) (US $MN)
Table 9 Global Real World Evidence Solutions Market By Services, Market Forecast (2015-2027) (US $MN)
Table 10 Global Real World Evidence Solutions Market By Data Sets , Market Forecast (2015-2027) (US $MN)
Table 11 Global Real World Evidence Solutions Market By Claims Data, Market Forecast (2015-2027) (US $MN)
Table 12 Global Real World Evidence Solutions Market By Patient-Powered Data, Market Forecast (2015-2027) (US $MN)
Table 13 Global Real World Evidence Solutions Market By Clinical Settings Data, Market Forecast (2015-2027) (US $MN)
Table 14 Global Real World Evidence Solutions Market By Pharmacy Data, Market Forecast (2015-2027) (US $MN)
Table 15 Global Real World Evidence Solutions Market By End User, Market Forecast (2015-2027) (US $MN)
Table 16 Global Real World Evidence Solutions Market By Healthcare Payers, Market Forecast (2015-2027) (US $MN)
Table 17 Global Real World Evidence Solutions Market By Pharmaceutical & Medical Device Companies, Market Forecast (2015-2027) (US $MN)
Table 18 Global Real World Evidence Solutions Market By Healthcare Providers, Market Forecast (2015-2027) (US $MN)
Table 19 Global Real World Evidence Solutions Market By Other End Users, Market Forecast (2015-2027) (US $MN)
Table 20 North America Real World Evidence Solutions Market By Country, Market Forecast (2015-2027) (US $MN)
Table 21 North America Real World Evidence Solutions Market By Therapeutic Area, Market Forecast (2015-2027) (US $MN)
Table 22 North America Real World Evidence Solutions Market By Cardiovascular Disease, Market Forecast (2015-2027) (US $MN)
Table 23 North America Real World Evidence Solutions Market By Immunology, Market Forecast (2015-2027) (US $MN)
Table 24 North America Real World Evidence Solutions Market By Oncology , Market Forecast (2015-2027) (US $MN)
Table 25 North America Real World Evidence Solutions Market By Neurology, Market Forecast (2015-2027) (US $MN)
Table 26 North America Real World Evidence Solutions Market By Other Therapeutic Areas, Market Forecast (2015-2027) (US $MN)
Table 27 North America Real World Evidence Solutions Market By Component, Market Forecast (2015-2027) (US $MN)
Table 28 North America Real World Evidence Solutions Market By Services, Market Forecast (2015-2027) (US $MN)
Table 29 North America Real World Evidence Solutions Market By Data Sets , Market Forecast (2015-2027) (US $MN)
Table 30 North America Real World Evidence Solutions Market By Claims Data, Market Forecast (2015-2027) (US $MN)
Table 31 North America Real World Evidence Solutions Market By Patient-Powered Data, Market Forecast (2015-2027) (US $MN)
Table 32 North America Real World Evidence Solutions Market By Clinical Settings Data, Market Forecast (2015-2027) (US $MN)
Table 33 North America Real World Evidence Solutions Market By Pharmacy Data, Market Forecast (2015-2027) (US $MN)
Table 34 North America Real World Evidence Solutions Market By End User, Market Forecast (2015-2027) (US $MN)
Table 35 North America Real World Evidence Solutions Market By Healthcare Payers, Market Forecast (2015-2027) (US $MN)
Table 36 North America Real World Evidence Solutions Market By Pharmaceutical & Medical Device Companies, Market Forecast (2015-2027) (US $MN)
Table 37 North America Real World Evidence Solutions Market By Healthcare Providers, Market Forecast (2015-2027) (US $MN)
Table 38 North America Real World Evidence Solutions Market By Other End Users, Market Forecast (2015-2027) (US $MN)
Table 39 Europe Real World Evidence Solutions Market By Country, Market Forecast (2015-2027) (US $MN)
Table 40 Europe Real World Evidence Solutions Market By Therapeutic Area, Market Forecast (2015-2027) (US $MN)
Table 41 Europe Real World Evidence Solutions Market By Cardiovascular Disease, Market Forecast (2015-2027) (US $MN)
Table 42 Europe Real World Evidence Solutions Market By Immunology, Market Forecast (2015-2027) (US $MN)
Table 43 Europe Real World Evidence Solutions Market By Oncology , Market Forecast (2015-2027) (US $MN)
Table 44 Europe Real World Evidence Solutions Market By Neurology, Market Forecast (2015-2027) (US $MN)
Table 45 Europe Real World Evidence Solutions Market By Other Therapeutic Areas, Market Forecast (2015-2027) (US $MN)
Table 46 Europe Real World Evidence Solutions Market By Component, Market Forecast (2015-2027) (US $MN)
Table 47 Europe Real World Evidence Solutions Market By Services, Market Forecast (2015-2027) (US $MN)
Table 48 Europe Real World Evidence Solutions Market By Data Sets , Market Forecast (2015-2027) (US $MN)
Table 49 Europe Real World Evidence Solutions Market By Claims Data, Market Forecast (2015-2027) (US $MN)
Table 50 Europe Real World Evidence Solutions Market By Patient-Powered Data, Market Forecast (2015-2027) (US $MN)
Table 51 Europe Real World Evidence Solutions Market By Clinical Settings Data, Market Forecast (2015-2027) (US $MN)
Table 52 Europe Real World Evidence Solutions Market By Pharmacy Data, Market Forecast (2015-2027) (US $MN)
Table 53 Europe Real World Evidence Solutions Market By End User, Market Forecast (2015-2027) (US $MN)
Table 54 Europe Real World Evidence Solutions Market By Healthcare Payers, Market Forecast (2015-2027) (US $MN)
Table 55 Europe Real World Evidence Solutions Market By Pharmaceutical & Medical Device Companies, Market Forecast (2015-2027) (US $MN)
Table 56 Europe Real World Evidence Solutions Market By Healthcare Providers, Market Forecast (2015-2027) (US $MN)
Table 57 Europe Real World Evidence Solutions Market By Other End Users, Market Forecast (2015-2027) (US $MN)
Table 58 Asia Pacific Real World Evidence Solutions Market By Country, Market Forecast (2015-2027) (US $MN)
Table 59 Asia Pacific Real World Evidence Solutions Market By Therapeutic Area, Market Forecast (2015-2027) (US $MN)
Table 60 Asia Pacific Real World Evidence Solutions Market By Cardiovascular Disease, Market Forecast (2015-2027) (US $MN)
Table 61 Asia Pacific Real World Evidence Solutions Market By Immunology, Market Forecast (2015-2027) (US $MN)
Table 62 Asia Pacific Real World Evidence Solutions Market By Oncology , Market Forecast (2015-2027) (US $MN)
Table 63 Asia Pacific Real World Evidence Solutions Market By Neurology, Market Forecast (2015-2027) (US $MN)
Table 64 Asia Pacific Real World Evidence Solutions Market By Other Therapeutic Areas, Market Forecast (2015-2027) (US $MN)
Table 65 Asia Pacific Real World Evidence Solutions Market By Component, Market Forecast (2015-2027) (US $MN)
Table 66 Asia Pacific Real World Evidence Solutions Market By Services, Market Forecast (2015-2027) (US $MN)
Table 67 Asia Pacific Real World Evidence Solutions Market By Data Sets , Market Forecast (2015-2027) (US $MN)
Table 68 Asia Pacific Real World Evidence Solutions Market By Claims Data, Market Forecast (2015-2027) (US $MN)
Table 69 Asia Pacific Real World Evidence Solutions Market By Patient-Powered Data, Market Forecast (2015-2027) (US $MN)
Table 70 Asia Pacific Real World Evidence Solutions Market By Clinical Settings Data, Market Forecast (2015-2027) (US $MN)
Table 71 Asia Pacific Real World Evidence Solutions Market By Pharmacy Data, Market Forecast (2015-2027) (US $MN)
Table 72 Asia Pacific Real World Evidence Solutions Market By End User, Market Forecast (2015-2027) (US $MN)
Table 73 Asia Pacific Real World Evidence Solutions Market By Healthcare Payers, Market Forecast (2015-2027) (US $MN)
Table 74 Asia Pacific Real World Evidence Solutions Market By Pharmaceutical & Medical Device Companies, Market Forecast (2015-2027) (US $MN)
Table 75 Asia Pacific Real World Evidence Solutions Market By Healthcare Providers, Market Forecast (2015-2027) (US $MN)
Table 76 Asia Pacific Real World Evidence Solutions Market By Other End Users, Market Forecast (2015-2027) (US $MN)
Table 77 Middle East Real World Evidence Solutions Market By Country, Market Forecast (2015-2027) (US $MN)
Table 78 Middle East Real World Evidence Solutions Market By Therapeutic Area, Market Forecast (2015-2027) (US $MN)
Table 79 Middle East Real World Evidence Solutions Market By Cardiovascular Disease, Market Forecast (2015-2027) (US $MN)
Table 80 Middle East Real World Evidence Solutions Market By Immunology, Market Forecast (2015-2027) (US $MN)
Table 81 Middle East Real World Evidence Solutions Market By Oncology , Market Forecast (2015-2027) (US $MN)
Table 82 Middle East Real World Evidence Solutions Market By Neurology, Market Forecast (2015-2027) (US $MN)
Table 83 Middle East Real World Evidence Solutions Market By Other Therapeutic Areas, Market Forecast (2015-2027) (US $MN)
Table 84 Middle East Real World Evidence Solutions Market By Component, Market Forecast (2015-2027) (US $MN)
Table 85 Middle East Real World Evidence Solutions Market By Services, Market Forecast (2015-2027) (US $MN)
Table 86 Middle East Real World Evidence Solutions Market By Data Sets , Market Forecast (2015-2027) (US $MN)
Table 87 Middle East Real World Evidence Solutions Market By Claims Data, Market Forecast (2015-2027) (US $MN)
Table 88 Middle East Real World Evidence Solutions Market By Patient-Powered Data, Market Forecast (2015-2027) (US $MN)
Table 89 Middle East Real World Evidence Solutions Market By Clinical Settings Data, Market Forecast (2015-2027) (US $MN)
Table 90 Middle East Real World Evidence Solutions Market By Pharmacy Data, Market Forecast (2015-2027) (US $MN)
Table 91 Middle East Real World Evidence Solutions Market By End User, Market Forecast (2015-2027) (US $MN)
Table 92 Middle East Real World Evidence Solutions Market By Healthcare Payers, Market Forecast (2015-2027) (US $MN)
Table 93 Middle East Real World Evidence Solutions Market By Pharmaceutical & Medical Device Companies, Market Forecast (2015-2027) (US $MN)
Table 94 Middle East Real World Evidence Solutions Market By Healthcare Providers, Market Forecast (2015-2027) (US $MN)
Table 95 Middle East Real World Evidence Solutions Market By Other End Users, Market Forecast (2015-2027) (US $MN)
Table 96 Latin America Real World Evidence Solutions Market By Country, Market Forecast (2015-2027) (US $MN)
Table 97 Latin America Real World Evidence Solutions Market By Therapeutic Area, Market Forecast (2015-2027) (US $MN)
Table 98 Latin America Real World Evidence Solutions Market By Cardiovascular Disease, Market Forecast (2015-2027) (US $MN)
Table 99 Latin America Real World Evidence Solutions Market By Immunology, Market Forecast (2015-2027) (US $MN)
Table 100 Latin America Real World Evidence Solutions Market By Oncology , Market Forecast (2015-2027) (US $MN)
Table 101 Latin America Real World Evidence Solutions Market By Neurology, Market Forecast (2015-2027) (US $MN)
Table 102 Latin America Real World Evidence Solutions Market By Other Therapeutic Areas, Market Forecast (2015-2027) (US $MN)
Table 103 Latin America Real World Evidence Solutions Market By Component, Market Forecast (2015-2027) (US $MN)
Table 104 Latin America Real World Evidence Solutions Market By Services, Market Forecast (2015-2027) (US $MN)
Table 105 Latin America Real World Evidence Solutions Market By Data Sets , Market Forecast (2015-2027) (US $MN)
Table 106 Latin America Real World Evidence Solutions Market By Claims Data, Market Forecast (2015-2027) (US $MN)
Table 107 Latin America Real World Evidence Solutions Market By Patient-Powered Data, Market Forecast (2015-2027) (US $MN)
Table 108 Latin America Real World Evidence Solutions Market By Clinical Settings Data, Market Forecast (2015-2027) (US $MN)
Table 109 Latin America Real World Evidence Solutions Market By Pharmacy Data, Market Forecast (2015-2027) (US $MN)
Table 110 Latin America Real World Evidence Solutions Market By End User, Market Forecast (2015-2027) (US $MN)
Table 111 Latin America Real World Evidence Solutions Market By Healthcare Payers, Market Forecast (2015-2027) (US $MN)
Table 112 Latin America Real World Evidence Solutions Market By Pharmaceutical & Medical Device Companies, Market Forecast (2015-2027) (US $MN)
Table 113 Latin America Real World Evidence Solutions Market By Healthcare Providers, Market Forecast (2015-2027) (US $MN)
Table 114 Latin America Real World Evidence Solutions Market By Other End Users, Market Forecast (2015-2027) (US $MN)
Table 115 RoW Real World Evidence Solutions Market By Country, Market Forecast (2015-2027) (US $MN)
Table 116 RoW Real World Evidence Solutions Market By Therapeutic Area, Market Forecast (2015-2027) (US $MN)
Table 117 RoW Real World Evidence Solutions Market By Cardiovascular Disease, Market Forecast (2015-2027) (US $MN)
Table 118 RoW Real World Evidence Solutions Market By Immunology, Market Forecast (2015-2027) (US $MN)
Table 119 RoW Real World Evidence Solutions Market By Oncology , Market Forecast (2015-2027) (US $MN)
Table 120 RoW Real World Evidence Solutions Market By Neurology, Market Forecast (2015-2027) (US $MN)
Table 121 RoW Real World Evidence Solutions Market By Other Therapeutic Areas, Market Forecast (2015-2027) (US $MN)
Table 122 RoW Real World Evidence Solutions Market By Component, Market Forecast (2015-2027) (US $MN)
Table 123 RoW Real World Evidence Solutions Market By Services, Market Forecast (2015-2027) (US $MN)
Table 124 RoW Real World Evidence Solutions Market By Data Sets , Market Forecast (2015-2027) (US $MN)
Table 125 RoW Real World Evidence Solutions Market By Claims Data, Market Forecast (2015-2027) (US $MN)
Table 126 RoW Real World Evidence Solutions Market By Patient-Powered Data, Market Forecast (2015-2027) (US $MN)
Table 127 RoW Real World Evidence Solutions Market By Clinical Settings Data, Market Forecast (2015-2027) (US $MN)
Table 128 RoW Real World Evidence Solutions Market By Pharmacy Data, Market Forecast (2015-2027) (US $MN)
Table 129 RoW Real World Evidence Solutions Market By End User, Market Forecast (2015-2027) (US $MN)
Table 130 RoW Real World Evidence Solutions Market By Healthcare Payers, Market Forecast (2015-2027) (US $MN)
Table 131 RoW Real World Evidence Solutions Market By Pharmaceutical & Medical Device Companies, Market Forecast (2015-2027) (US $MN)
Table 132 RoW Real World Evidence Solutions Market By Healthcare Providers, Market Forecast (2015-2027) (US $MN)
Table 133 RoW Real World Evidence Solutions Market By Other End Users, Market Forecast (2015-2027) (US $MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report